47
https://pubmed.ncbi.nlm.nih.gov/38112064
The systematic review of nine studies suggests that combining methotrexate with other oral disease-modifying antirheumatic drugs could be a potential alternative for psoriatic arthritis patients who have an inadequate response to monotherapy or no access to biologics.